Cingulate Inc. to Present at the LD Micro Main Event XVI

2 years ago

Presentation on Wednesday, October 4th at 02:30 PM PTKANSAS CITY, Kan., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:CING), a…

Brain Canada’s flagship program awards $2.8 million for brain research

2 years ago

Brain Canada’s Future Leaders in Canadian Brain Research program to support 28 early-career researchers this year The 2022 Future Leaders…

Mithra to Hold Investor Call on H1 2023 Financial Results on September 26 at 14:00 CEST

2 years ago

Mithra to Hold Investor Call on H1 2023 Financial Results on September 26 at 14:00 CEST Liege, Belgium, September 21,…

Information on the total number of voting rights (denominator)

2 years ago

Information on the total number of voting rights (denominator) Liege, Belgium, 21 September 2023 – 5:45 pm CEST – Mithra…

LSL Pharma Group Announces Brokered Private Placement of Convertible Debentures of Up to $4,000,000

2 years ago

Debenture proceeds will provide additional funds and flexibility for growthBOUCHERVILLE, Québec, Sept. 21, 2023 (GLOBE NEWSWIRE) -- LSL Pharma Group…

New Mobile Medical Company Launches in Calgary to Provide Fast, Convenient Access to Lab Services

2 years ago

CALGARY, Alberta, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Mobile medical provider Scrubs Health Inc. (Scrubs™) is pleased to announce it…

U.S. Food and Drug Administration Approves Orphan Drug Designation for Nexcella NXC-201 as a Treatment for Amyloid Light Chain (AL) Amyloidosis

2 years ago

FDA Orphan Drug Designation (“ODD”) qualifies one-time treatment NXC-201 for: 7 years of U.S. market exclusivity after approval Tax credits…

Safe Supply Streaming Co. Ltd. Completes Reverse Take-Over Transaction and Prepares for Listing on the Canadian Securities Exchange

2 years ago

Toronto, Ontario--(Newsfile Corp. - September 22, 2023) - Safe Supply Streaming Co. Ltd. (formerly Origin Therapeutics Inc.) ("Safe Supply" or…

Skye Bioscience Announces Participation at Upcoming Investor Conferences

2 years ago

San Diego, California--(Newsfile Corp. - September 22, 2023) - Skye Bioscience, Inc. (OTCQB: SKYED) ("Skye" or the "Company"), a pharmaceutical…